XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

The Company classifies fair value-based measurements using a three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: Level 1, quoted market prices (unadjusted) in active markets for identical assets or liabilities; Level 2, observable inputs other than quoted market prices included in Level 1, such as quoted market prices for markets that are not active or other inputs that are observable or can be corroborated by observable market data; and Level 3, unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities, including certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

As of March 31, 2023 and December 31, 2022, the Company’s financial assets and liabilities recognized at fair value on a recurring basis consisted of the following:

 

 

Fair Value as of March 31, 2023

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(In thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents and restricted cash equivalents

 

$

278,233

 

 

$

278,233

 

 

$

-

 

 

$

-

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

 

261,537

 

 

 

124,059

 

 

 

137,478

 

 

 

-

 

Financial institution debt securities

 

 

459,502

 

 

 

-

 

 

 

459,502

 

 

 

-

 

Corporate debt securities

 

 

107,023

 

 

 

-

 

 

 

107,023

 

 

 

-

 

Other asset-backed securities

 

 

36,368

 

 

 

-

 

 

 

36,368

 

 

 

-

 

Total marketable securities

 

 

864,430

 

 

 

124,059

 

 

 

740,371

 

 

 

-

 

Total Assets

 

$

1,142,663

 

 

$

402,292

 

 

$

740,371

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value as of December 31, 2022

 

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

 

(In thousands)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents and restricted cash equivalents

 

$

534,581

 

 

$

534,581

 

 

$

-

 

 

$

-

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

 

242,686

 

 

 

172,939

 

 

 

69,747

 

 

 

-

 

Financial institution debt securities

 

 

379,861

 

 

 

-

 

 

 

379,861

 

 

 

-

 

Corporate debt securities

 

 

101,550

 

 

 

-

 

 

 

101,550

 

 

 

-

 

Other asset-backed securities

 

 

14,357

 

 

 

-

 

 

 

14,357

 

 

 

-

 

Total marketable securities

 

 

738,454

 

 

 

172,939

 

 

 

565,515

 

 

 

-

 

Total Assets

 

$

1,273,035

 

 

$

707,520

 

 

$

565,515

 

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certain of the Company’s financial assets, including cash equivalents, restricted cash equivalents and marketable securities, have been initially valued at the transaction price, and subsequently revalued at the end of each reporting period, utilizing third party pricing services or other observable market data. The pricing services utilize industry standard valuation models and observable market inputs to determine value. After completing its validation procedures, the Company did not adjust or override any fair value measurements provided by the pricing services as of March 31, 2023 or December 31, 2022.

Other financial instruments, including accounts receivable, accounts payable and accrued expense, are carried at cost, which approximates fair value due to the short duration and term to maturity.

As discussed further in Note 9, under the Rewrite Merger Agreement, the Rewrite Holders received a $25.0 million research milestone payment in February of 2023, paid in a combination of $0.9 million in cash and the remainder in the Company’s common stock. The milestone payable in the Company’s common stock resulted in liability classification under ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). This contingent consideration liability was carried at fair value which was estimated by applying a probability-based model, which utilized inputs based on timing of achievement that were unobservable in the market. The contingent consideration liability was classified within Level 3 of the fair value hierarchy until it was settled in February of 2023.

The following table reconciles the change in fair value of the contingent consideration liability based on the level 3 inputs listed below (in thousands):

 

For the three months ended March 31, 2023

 

Balance at December 31, 2022

$

24,026

 

Change in fair value

 

100

 

Payment of contingent consideration

 

(24,126

)

Balance at March 31, 2023

$

-

 

 

 

December 31, 2022

Discount rate

10.1%

Probability of achievement

100%

Projected year of achievement

2023